Sun Pharma
Anil Singhvi’s Strategy September 6: Market Trend is Neutral; Metal sector is Positive; NBFC is Negative
Fri, Sep 06, 2019
On account of positive global markets, DIIs, neutral F&O and negative FIIs, the short-term trend of the Indian markets will be neutral, says Zee Business Managing Editor Anil Singhvi.
More >
Stocks in Focus on September 6: Sun Pharma, Reliance Industries to Tech Mahindra; here are the 5 Newsmakers of the Day
Fri, Sep 06, 2019
Reliance Industries, Sun Pharmaceutical Industries, Bajaj Finance, L&T Finance Holdings and Tech Mahindra are the top 5 stocks that would remain in focus today.
More >
Anil Singhvi’s Strategy September 4: Market Trend & Sentiment are Negative; Sell Sun Pharma Futures with Stop Loss 445
Wed, Sep 04, 2019
On account of positive DIIs, neutral F&O and negative FIIs, the short-term trend of the domestic Indian markets will continue to be negative, says Zee Business Managing Editor Anil Singhvi.
More >
Stocks in Focus on September 4: Sun Pharma, Aditya Birla Capital to Varun Beverages; here are the 5 Newsmakers of the Day
Wed, Sep 04, 2019
Sun Pharma, Aditya Birla Capital, Edelweiss Financial Services, VST Tillers Tractors and Varun Beverages are the stocks that would remain in focus today.
More >
Sensex scales on ease in China-US trade tension, Nifty regains 11K; Tata Steel, Vodafone Idea, Sun Pharma stocks gain
Fri, Aug 30, 2019
The BSE Sensex scaled 263 points and closed at 37,332 levels while the 50-stock Nifty rose 74 points and regained the psychological 11,000 levels after closing at 11,021 levels.
More >
Sun Pharma stock tumbles 8.5 per cent at market closing: Should you buy? Check for Rs 420 magical figure
Fri, Jan 18, 2019
Sr. Equity Analyst, Rohit Singre, LKP Securities told Zee Business Online, ''The stock is down because of news, however technically it is weak right now. Investors are suggested to avoid until further clearance on the allegations.''
More >
Sun Pharma tumbles on reports of fresh whistleblower complaint
Fri, Jan 18, 2019
The whistleblower alleged in a 172-page complaint that Sun Pharma`s distributor Aditya Medisales had transactions worth more than 58 billion rupees ($815 million) with Suraksha Realty, controlled by Sun`s co-promoter Sudhir Valia, a report by Moneylife magazine said.
More >
